ADA COMPLETE Trademark

Trademark Overview


On Friday, March 15, 2024, a trademark application was filed for ADA COMPLETE with the United States Patent and Trademark Office. The USPTO has given the ADA COMPLETE trademark a serial number of 98451154. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, October 1, 2024. This trademark is owned by AbbVie Biotechnology Ltd. The ADA COMPLETE trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Providing a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof; none of the foregoing services in the field of oral or dental health

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites; none of the foregoing services in the field of oral or dental health
ada complete

General Information


Serial Number98451154
Word MarkADA COMPLETE
Filing DateFriday, March 15, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof; none of the foregoing services in the field of oral or dental health
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites; none of the foregoing services in the field of oral or dental health

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, March 15, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 15, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHamilton HM11
BM

Trademark Events


Event DateEvent Description
Sunday, March 17, 2024NEW APPLICATION ENTERED
Thursday, August 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 25, 2024ASSIGNED TO EXAMINER
Tuesday, October 1, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, December 18, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED